Extract:
“Clinical trial evidence suggests that Kurin Lock is a safe and effective way of reducing blood culture contamination rates, compared with standard blood culture collection. It is not clear how it affects other outcomes, like length of hospital stay and antibiotic use, because the clinical trials did not formally record these outcomes.
The economic modelling is also uncertain, and it is unclear if Kurin Lock is cost incurring or cost saving. Kurin Lock costs much more than standard blood culture collection. So, it is more likely that Kurin Lock is cost saving when it is used in emergency departments with high rates of blood culture contamination. The external assessment group (EAG) estimated that if Kurin Lock reduces length of stay by only 0.5 days, and the baseline contamination rate in the department is 8%, the cost of a Kurin Lock device would need to be £10 rather than £19.50 to be cost neutral”.
Reference:Kurin Lock for blood culture collection (MTG77). Medical technologies guidance. Published: 3 April 2024. www.nice.org.uk/guidance/mtg77